Tremella fuciformis polysaccharide reduces obesity in high-fat diet-fed mice by modulation of gut microbiota
Authors:
Open Access
- 5 December 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 1073350
Abstract
Obesity is a metabolic disease associated with gut microbiota and low-grade chronic inflammation. Tremella fuciformis is a medicinal and edible fungus; polysaccharide (TP) is the main active component, which has a variety of biological activities, such as hypoglycemic and hypolipidemic. However, the anti-obesity effects and potential mechanisms of TP have never been reported. This study was conducted to elucidate the inhibitory effect of TP on high-fat diet (HFD)-induced obesity in mice. Mice were split into five groups: normal chow diet (NCD) group, NCD_TP_H group, HFD group, HFD_TP_L group and HFD_TP_H group. Our study showed that TP inhibited high-fat diet-induced weight gain and fat accumulation in mice and reduced blood glucose, hyperlipidemia and inflammation. TP also improved gut microbiota disorders by reducing the Firmicutes/Bacteroidetes ratio and modulating the relative abundance of specific gut microbiota. We also found that the anti-obesity and gut microbiota-modulating effects of TP could be transferred to HFD-fed mice via faecal microbiota transplantation (FMT), confirming that the gut microbiota was one of the targets of TP for obesity inhibition. Further studies showed that TP increased the production of short-chain fatty acids and the secretion of intestinal hormones. Our studies showed that TP inhibited obesity by modulating inflammation and the microbe-gut-brain axis, providing a rationale for developing TP to treat obesity and its complications.Keywords
Funding Information
- National Natural Science Foundation of China (31870655)
This publication has 80 references indexed in Scilit:
- Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in MiceScience, 2013
- High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling PathwayPLOS ONE, 2012
- Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent MechanismsPLOS ONE, 2012
- Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2Diabetes, 2012
- Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic miceProceedings of the National Academy of Sciences, 2011
- Adipokines in inflammation and metabolic diseaseNature Reviews Immunology, 2011
- Optimization of extraction of Tremella fuciformis polysaccharides and its antioxidant and antitumour activities in vitroCarbohydrate Polymers, 2010
- Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeabilityGut, 2009
- Global burden of obesity in 2005 and projections to 2030International Journal of Obesity, 2008
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006